Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News TELA Bio Inc TELA

Healthcare Medical Instruments & Supplies
TELA Bio, Inc. is a commercial-stage medical technology company. The Company is focused on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s own anatomy. Its first portfolio of products, the OviTex Reinforced Tissue Matrix (OviTex), addresses unmet needs in hernia repair and abdominal wall... see more

Recent & Breaking News (NDAQ:TELA)

TELA Bio Announces U.S. Commercial Launch of NIVIS(TM) Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds

GlobeNewswire January 9, 2023

TELA Bio to Participate in the 41st Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 21, 2022

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire December 9, 2022

TELA Bio to Participate in Piper Sandler 34th Annual Healthcare Conference

GlobeNewswire November 21, 2022

TELA Bio Reports Third Quarter 2022 Financial Results

GlobeNewswire November 9, 2022

TELA Bio to Participate in Canaccord MedTech, Diagnostics and Digital Health & Services Forum

GlobeNewswire November 3, 2022

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire October 28, 2022

TELA Bio to Announce Third Quarter 2022 Financial Results

GlobeNewswire October 27, 2022

TELA Bio Announces Publication of 24-Month BRAVO Study Results Demonstrating Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repair

GlobeNewswire October 26, 2022

TELA Bio to Participate in Upcoming Investor Conferences

GlobeNewswire September 1, 2022

TELA Bio to Participate in Inaugural Gilmartin Group Emerging Growth Company Showcase

GlobeNewswire August 23, 2022

TELA Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriter's Option to Purchase Additional Shares

GlobeNewswire August 18, 2022

TELA Bio Announces Pricing of Public Offering of Common Stock

GlobeNewswire August 15, 2022

TELA Bio Announces Proposed Public Offering of Common Stock

GlobeNewswire August 15, 2022

TELA Bio Reports Second Quarter 2022 Financial Results

GlobeNewswire August 10, 2022

TELA Bio to Participate in Upcoming Investor Conferences

GlobeNewswire August 5, 2022

TELA Bio Highlights Results from BRAVO and ReBAR Studies on the Benefits of OviTex® Reinforced Tissue Matrix in Hernia Repairs; Data to Be Presented at 2022 American Hernia Society (AHS) Meeting

GlobeNewswire August 4, 2022

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire July 29, 2022

TELA Bio to Announce Second Quarter 2022 Financial Results

GlobeNewswire July 27, 2022

TELA Bio Awarded Synthetic Bioabsorbable Mesh Products Agreement with Premier, Inc.

GlobeNewswire July 20, 2022